The invention is directed to a cross-screening system and methods of the
invention utilizing a combination of an immunoassay (IA) and
electrochemiluminescence assay (ECLA) to identify molecules that have
binding affinities for a target molecule. The cross-screening system and
methods of the invention can detect molecules that have binding
affinities for the target molecule below the detection limits of the
individual immunoassay or ECLA. The cross-screening system and methods of
the invention are useful for generating a pool of candidate analyte
molecules enriched in a desired characteristic, such as low binding
affinity for a target molecule. Low affinity antibodies identified by the
cross-screening system and methods of the invention are useful, for
example, in assessing the safety and efficacy of biological therapeutics.